{"organizations": [], "uuid": "4804e9ac491edd459ca38df42dc14c7f8ca86d89", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 2, "shares": 2, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/01/12/104944442-6ED4-MM-D-BLOCK-011218.600x400.jpg", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/01/12/alder-biopharmaceuticals-ceo-migraine-medicine-closer-to-fda-approval.html", "country": "US", "domain_rank": 767, "title": "Breakthrough treatment for migraines on path to FDA approval, biotech CEO says", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-13T02:00:00.000+02:00", "replies_count": 0, "uuid": "4804e9ac491edd459ca38df42dc14c7f8ca86d89"}, "author": "", "url": "https://www.cnbc.com/video/2018/01/12/alder-biopharmaceuticals-ceo-migraine-medicine-closer-to-fda-approval.html", "ord_in_thread": 0, "title": "Breakthrough treatment for migraines on path to FDA approval, biotech CEO says", "locations": [], "entities": {"persons": [{"name": "jim crame", "sentiment": "negative"}, {"name": "randall shatzman", "sentiment": "none"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "alder biopharmaceuticals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Breakthrough treatment for migraines on path to FDA approval, biotech CEO says 19 Hours Ago Jim Cramer caught up with Alder Biopharmaceuticals co-founder and CEO Randall Shatzman about his company's treatment for severe migraines.", "external_links": [], "published": "2018-01-13T02:00:00.000+02:00", "crawled": "2018-01-13T02:54:54.001+02:00", "highlightTitle": ""}